PRESS RELEASE : Vivoryon Therapeutics N.V.: Vivoryon Therape

DGAP-News: Vivoryon Therapeutics N.V. / Key word: Study Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Provides Update on Business and Progress of Varoglutamstat Clinical Development in... | October 18, 2021

Related Keywords

Germany , United States , Netherlands , Poland , Spain , German , Ulrich Dauer , Howard Feldman , School Of Medicine , National Institutes Of Health , Us Clinical Development Of Varoglutamstat , Nasdaq , Exchange Commission , Alzheimer Disease Cooperative Study , Journal Alzheimer Research Therapy , University Of California San Diego , National Institute On Aging , Vivoryon Therapeutics Provides Update , Varoglutamstat Clinical Development , Therapeutics Provides Update , Disease This , Inside Information , Market Abuse Regulation , Germany October , Euronext Amsterdam , European Phase , Neuropsychological Test Battery , Disease Cooperative Study , California San Diego , National Institute , National Institutes , Update Measures , Dow Jones , Vivoryon Therapeuticsnv Stock Exchange , News , Information , Press Release , Vivoryon , Herapeutics , Key , Study , Rovides , Update , N , Business , End , Progress , F , Aroglutamstat , Linical , Evelopment Vvy Nl00150002q7 ,